Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00095199
Status:
COMPLETED
Last Update Posted:
2012-10-15
First Post:
2004-11-01
Brief Title:
Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
Sponsor:
Organization:
Eli Lilly and Company